Evidence map›Paper›PMID 28838979›Full record

ReviewThe European respiratory journal2017

Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Markus Glatzer, Achim Rittmeyer, Joachim Müller, Isabelle Opitz, Alexandros Papachristofilou, Ioannis Psallidas, Martin Früh, Diana Born, Paul Martin Putora

Abstract readReview
PubMed Publisher
In one paragraph

Review in The European respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Retrospective Study of Patients with GABANeuropsychiatric disease and treatment · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Markus GlatzerDept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland markus.glatzer@kssg.ch.
Achim RittmeyerDept of Thoracic Oncology, Lungenfachklinik Immenhausen, Immenhausen, Germany.
Joachim MüllerDept of Radiology and Nuclear Medicine, Kantonsspital St Gallen, St Gallen, Switzerland.
Isabelle OpitzDept of Thoracic Surgery, University Hospital Zürich, Zürich, Switzerland.
Alexandros PapachristofilouDept of Radiation Oncology, University Hospital Basel, Basel, Switzerland.
Ioannis PsallidasOxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.
Martin FrühDept of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland.
Diana BornInstitute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland.
Paul Martin PutoraDept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of limited disease SCLC and how this can contribute towards improving outcomes.

Indexed as

Lung NeoplasmsSmall Cell Lung CarcinomaHumansPatient Care ManagementPatient Care TeamTime-to-TreatmentTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.